Johnson & Johnson COVID Vaccine Recipients Almost 4X as Likely to Get Blood Clots: Study – Newsweek

Post author By EvidenceNotFear
Post date 2 November 2021

A new study conducted in one county in Minnesota has found an increased likelihood that citizens who received the Johnson & Johnson’s COVID-19 vaccine were more likely to develop blood clots.

The study by the Mayo Clinic found that recipients of the Johnson & Johnson vaccine, officially designated “Janssen,” in Olmsted County, Minnesota, were about 3.7 times more likely to develop a certain variety of cerebral blood clots. Case numbers taken from February 28 to May 7, 2021, were compared to pre-pandemic levels of the blood clots from January 1, 2001, through December 31, 2015.

http://archive.today/2021.11.03-081828/https://www.newsweek.com/johnson-johnson-covid-vaccine-recipients-almost-4x-likely-get-blood-clots-study-1645100

Tags AstraZeneca, Blood Clots, COVID-19, CVST, Emergency Use Authorization, FDA, Guillain-Barré Syndrome, Janssen, Johnson & Johnson, Mayo Clinic, Newsweek, Side-effects, USA, Vaccination, Vaccine Damage

Info This site is a curated archive of articles with a link to the source. Keywords and topics covered in the publication can be found above. Click on the tag to view a listing of similar articles.
Links Are any links broken? The page may have been taken down. Visit archive.is or archive.org to view the archive snapshot.
Links Help fight censorship and preserve information on the internet. Archive this source and links on archive.is and archive.org. Save a local copy on your own hard drive.